Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
7 p, 793.0 KB Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation : A retrospective analysis of the EBMT chronic malignancies working party / Scheid, C. (University of Cologne) ; De Wreede, L. (DKMS. German Bone Marrow Donor Center) ; Van Biezen, A. (Leiden University Medical Center) ; Koenecke, C. (Hannover Medical School) ; Göhring, G. (Hannover Medical School) ; Volin, L. (HUCH Comprehensive Cancer Center) ; Maertens, J. (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Finke, J. (University of Freiburg) ; Passweg, J. (University Hospital) ; Beelen, D. (University Hospital) ; Cornelissen, J. J. (University Medical Center Rotterdam) ; Itälä-Remes, M. (Turku University Hospital (Finlàndia)) ; Chevallier, P. (CHU Nantes) ; Russell, N. (Nottingham University) ; Petersen, E. (University Medical Centre) ; Milpied, N. (Hôpital Haut-leveque) ; Richard Espiga, C. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Peniket, A. (Churchill Hospital) ; Sierra Llopart, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Mufti, G. (GKT School of Medicine) ; Crawley, C. (Addenbrookes Hospital (Cambridge, Regne Unit)) ; Veelken, J.H. (Leiden University Hospital) ; Ljungman, P. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Cahn, Jean-Yves (Hopital A. Michallon) ; Alessandrino, E.P. (Fondazione IRCCS Policlinico San Matteo) ; De Witte, T. (Radboud University-Nijmegen Medical Centre) ; Robin, M. (Hopital St. Louis) ; Kröger, N. (University Hospital Eppendorf) ; Universitat Autònoma de Barcelona
The International Prognostic Scoring System has been revised (IPSS-R) to predict prognosis of patients with myelodysplastic syndromes at diagnosis. To validate the use of the IPSS-R assessed before transplant rather than at diagnosis we performed a retrospective analysis of the EBMT database. [...]
2017 - 10.1038/bmt.2017.171
Bone marrow transplantation, Vol. 52 Núm. 11 (january 2017) , p. 1519-1525  
2.
13 p, 1.7 MB A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation / Cremers, Eline M.P. (VU University Medical Centre) ; de Witte, Theo (Radboud University Medical Centre) ; de Wreede, Liesbeth C. (Leiden University Medical Center) ; Eikema, Diderik-Jan (EBMT Statistical Unit Data Office Leiden) ; Koster, Linda (EBMT Data Office Leiden) ; van Biezen, Anja (EBMT Data Office Leiden) ; Finke, Jürgen (University of Freiburg) ; Socié, Gerard (Hospital St. Louis) ; Beelen, Dietrich (University Hospital) ; Maertens, Johan (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Nagler, Arnon (Chaim Sheba Medical Center (Israel)) ; Kobbe, Guido (Heinrich Heine Universitaet) ; Ziagkos, Dimitris (EBMT Statistical Unit Data Office Leiden) ; Itälä-Remes, Maija (HUCH Comprehensive Cancer Center) ; Gedde-Dahl, Tobias (Oslo University Hospital (Oslo, Noruega)) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Niederwieser, Dietger (University Hospital Leipzig) ; Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Beguin, Yves (University of Liège) ; Ozkurt, Zubeyde Nur (Gazi University) ; Anagnostopoulos, Achilles (George Papanicolaou General Hospital (Tessalònia, Grècia)) ; Jindra, Pavel (Charles University Hospital) ; Robin, Marie (Hospital St. Louis) ; Kröger, Nicolaus (University Hospital Eppendorf) ; Universitat Autònoma de Barcelona
Most myelodysplastic syndromes (MDS)-patients receive multiple red blood cell transfusions (RBCT). Transfusions may cause iron-related toxicity and mortality, influencing outcome after allogeneic HSCT. [...]
2019 - 10.1080/10428194.2019.1594215
Leukemia and Lymphoma, Vol. 60 Núm. 10 (2019) , p. 2404-2414  
3.
7 p, 363.5 KB The EHA Research Roadmap : Malignant Myeloid Diseases / Döhner, Hartmut (Department of Internal Medicine III. Ulm University Hospital) ; Malcovati, Luca (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS)) ; Ossenkoppele, Gert J. (Amsterdam UMC. Department of Hematology. VU University. Medical Center) ; Hochhaus, Andreas (Universitätsklinikum Jena. Klinik für Innere Medizin II. Hämatologie/Onkologie) ; Maria Vannucchi, Alessandro (Center Research and Innovation of Myeloproliferative Neoplasms. CRIMM. University of Florence) ; Bullinger, Lars (Freie Universität Berlin) ; Cervantes, Francisco (Hospital Clínic i Provincial de Barcelona) ; Craddock, Charles (Centre for Clinical Haematology. Queen Elizabeth Hospital) ; de Witte, Theo. (Radboud University. Medical Centre. Nijmegen) ; Döhner, Konstanze (Department of Internal Medicine III. Ulm University Hospital) ; Dombret, Hervé (Institut de Recherche Saint-Louis (IRSL). Université de Paris. Hôpital Saint-Louis) ; Fenaux, Pierre (Département (DMU) d'Hématologie et Immunologie. Assistance Publique Hôpitaux de Paris. Hôpital St Louis. Université de Paris) ; Geissler, Jan (Leukemia Patient Advocates Foundation) ; Germing, Ulrich (Klinik für Hämatologie. Onkologie und Klinische Immunologie. Universitätsklinikum Düsseldorf. Heinrich-Heine Universität Düsseldorf) ; Guilhot, Francois (University of Poitiers) ; Harrison, Claire (Department of Haematology. Guys and St thomas'Hospital) ; Hellström-Lindberg, Eva (Karolinska Institutet (Estocolm, Suècia)) ; Passamonti, Francesco (Department of Clinical and Biological Sciences. University of Turin. San Luigi University Hospital) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Skoda, Radek (University Hospital Basel (Basilea, Suïssa)) ; Wierzbowska, Agnieszka. (Multi-specialized Center of Oncology and Traumatology)
In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. [...]
2021 - 10.1097/HS9.0000000000000635
HemaSphere, Vol. 5 Núm. 9 (2021)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.